The CCAAT/enhancer-binding protein beta-2 isoform (CEBPβ-2) upregulates galectin-7 expression in human breast cancer cells.
Galectin-7 is considered a gene under the control of p53. However, elevated expression of galectin-7 has been reported in several forms of cancer harboring an inactive p53 pathway. This is especially true for breast cancer where galectin-7 expression is readily expressed in a high proportion in basa...
Main Authors: | Carole G Campion, Marilyne Labrie, Andrée-Anne Grosset, Yves St-Pierre |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4008383?pdf=render |
Similar Items
-
Expression of galectin-7 is induced in breast cancer cells by mutant p53.
by: Carole G Campion, et al.
Published: (2013-01-01) -
Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer.
by: Andrée-Anne Grosset, et al.
Published: (2016-01-01) -
A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer.
by: Marilyne Labrie, et al.
Published: (2015-01-01) -
THE ROLE OF CCAAT/ENHANCER BINDING PROTEIN BETA2 IN MAMMARY EPITHELIAL CELLS
by: Russell, Alisha Joy
Published: (2010) -
Role of specific CCAAT/enhancer-binding protein isoforms in intestinal epithelial cells
by: Gheorghiu, Ionela
Published: (2001)